Insider Trading History of Oliveto Joseph

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Oliveto Joseph since 2010. The trader's CIK number is 1437782. At the time of the last reporting, Oliveto Joseph was the Vice President of Operations of Milestone Pharmaceuticals Inc.. (stock ticker symbol MIST). Also see all insider trading activities at Milestone Pharmaceuticals Inc..

Note that in the past Oliveto Joseph also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Chelsea Therapeutics International, Ltd. (CHTP) by Oliveto Joseph

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 CHTP 0 $0 0 $0 490,000 $1,317,120
2010 CHTP 3,500 $10,045 0 $0 0 $0

Yearly summary of insider trading at Milestone Pharmaceuticals Inc. (MIST) by Oliveto Joseph

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MIST 0 $0 0 $0 7,400 $11,396


Insider trading activities at 2 companies by Oliveto Joseph:

1. Chelsea Therapeutics International, Ltd. (CHTP)

2. Milestone Pharmaceuticals Inc. (MIST)

Table 1. Insider trading of Chelsea Therapeutics International, Ltd. (CHTP) by Oliveto Joseph

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-06-23 CHTP Option Ex 490,000 2.69 1,317,120
2010-08-12 CHTP Buy 3,500 2.87 10,045

Table 2. Insider trading of Milestone Pharmaceuticals Inc. (MIST) by Oliveto Joseph

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-21 MIST Option Ex 7,400 1.54 11,396

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oliveto Joseph (Vice President of Operations of Milestone Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.